XML 22 R2.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Net sales $ 7,320,104 $ 3,327,957 $ 3,128,909
Cost of goods sold 4,245,517 2,329,986 2,134,056
Gross profit 3,074,587 997,971 994,853
Selling, general and administrative expenses 524,145 441,482 429,827
Research and development expenses 71,981 54,026 59,214
Loss (gain) on sale of business/interest in properties, net 8,400 (295,971) 0
Operating profit 2,470,061 798,434 505,812
Interest and financing expenses (122,973) (61,476) (73,116)
Other income (expenses), net 86,356 (603,340) (59,177)
Income before income taxes and equity in net income of unconsolidated investments 2,433,444 133,618 373,519
Income tax expense 390,588 29,446 54,425
Income before equity in net income of unconsolidated investments 2,042,856 104,172 319,094
Equity in net income of unconsolidated investments (net of tax) 772,275 95,770 127,521
Net income 2,815,131 199,942 446,615
Net income attributable to noncontrolling interests (125,315) (76,270) (70,851)
Net income attributable to Albemarle Corporation $ 2,689,816 $ 123,672 $ 375,764
Basic earnings per share (in dollars per share) $ 22.97 $ 1.07 $ 3.53
Diluted earnings per share (in dollars per share) $ 22.84 $ 1.06 $ 3.52
Weighted-average common shares outstanding—basic (in shares) 117,120 115,841 106,402
Weighted-average common shares outstanding—diluted (in shares) 117,793 116,536 106,808